• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION AND THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • ADDICTION & DOPAMINE
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING BRAIN
      • FASTING CANCER
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUTAMATE & BRAIN
      • GLYCATION
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • MENAQUINONE 4
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME EXTRACT
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RECEPTOR “Κ OPIOID”
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
    February 19, 2021
    BRASSINOSTEROIDS
    February 19, 2021
    1. A comparative study on the effects of high-fat diet and endurance training on the PGC-1α-FNDC5/Irisin pathway in obese and nonobese male C57BL/6 mice
    2. A COMPARISON OF THE EFFECTS OF RESISTANCE AND ENDURANCE TRAINING PROTOCOLS ON SERUM Irisin LEVEL AND ALKALINE …
    3. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein Irisin in biological tissues
    4. A glance at the therapeutic potential of Irisin against diseases involving inflammation, oxidative stress, and apoptosis: an introductory review
    5. A new member of the myokine family: Irisin
    6. A novel interplay between Irisin and PTH: from basic studies to clinical evidence in hyperparathyroidism
    7. A novel treatment for weight reduction by the recombinant “Pichia pastoris” yeast expressing the hybrid protein of “Irisin-furin-transferrin”
    8. A pilot study on the relation between Irisin single-nucleotide polymorphism and risk of myocardial infarction
    9. A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3′ UTR
    10. A randomized-controlled trial pilot study examining the effect of pelvic floor muscle training on the Irisin concentration in overweight or obese elderly women …
    11. A review on Irisin, a new protagonist that mediates muscle-adipose-bone-neuron connectivity
    12. A review on the role of Irisin in insulin resistance and type 2 diabetes mellitus
    13. A role for FNDC5/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases
    14. A Study on the Impact of Irisin
    15. A transient elevated Irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women
    16. A11957 Irisin Lowers Blood Pressure by Improvement of Endothelial Dysfunction via AMPK-Akt-eNOS-NO Pathway in the Spontaneously Hypertensive Rat
    17. AB0057 Decreased Irisin level as risk factor of pathological fractures in rheumatoid arthritis patients
    18. AB0116 DECREASED SERUM LEVEL OF Irisin IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    19. AB0327 SERUM Irisin LEVELS IN HEALTHY WOMEN AND PATIENTS WITH RHEUMATOID ARTHRITIS
    20. AB0349 The serum level of Irisin is decreased in the patients with rheumatoid arthritis
    21. AB0962 Irisin levels are associated with exercise, pain and function in patients with knee osteoarthritis
    22. Abnormal Irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients
    23. Abstract P241: Irisin Protects Mitochondria Function During Pulmonary Ischemia Reperfusion Injury
    24. Acute anaerobic exercise affects the secretion of asprosin, Irisin, and other cytokines–a comparison between sexes
    25. Acute and chronic effects of aerobic exercise on serum Irisin, adropin, and cholesterol levels in the winter season: Indoor training versus outdoor training
    26. ACUTE EFFECT OF ENDURANCE EXERCISE ON PLASMA Irisin AND INSULIN RESISTANCE IN OBESE/OVER WEIGHT WOMEN
    27. Acute Effects of Aerobic Treadmill Exercise Intensity on Expression of Irisin and FNDC5 in Male Mouse
    28. Acute exercise training and circulating Irisin in adult mens
    29. Acute exercise-induced Irisin release in healthy adults: Associations with training status and exercise mode
    30. Acute Postexercise Change in Circulating Irisin Is Related to More Favorable Lipid Profile in Pregnant Women Attending a Structured Exercise Program and to …
    31. Adiponectin profile and Irisin expression in Italian obese children: Association with insulin-resistance
    32. Adropin and Irisin in arterial hypertension, diabetes mellitus and chronic kidney disease.
    33. Adropin and Irisin in patients with cardiac cachexia
    34. Adropin and Irisin levels in a rat model of hypothyroidism
    35. Adropin and Irisin levels in relation to nutrition, body composition, and insulin resistance in patients with end-stage renal disease on chronic hemodialysis and …
    36. Adropin and Irisin: New biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study
    37. Adropin and Irisin: New biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study
    38. Aerobic exercise alleviates oxidative stress-induced apoptosis in kidneys of myocardial infarction mice by inhibiting ALCAT1 and activating FNDC5/Irisin signaling …
    39. Aerobic Exercise Training-induced Increase in Circulating Irisin Level is Associated With Reduced Arterial Stiffness in Obesity
    40. Aerobic exercise training-induced Irisin secretion is associated with the reduction of arterial stiffness via nitric oxide production in adults with obesity
    41. AGE-RELATED CHANGES OF Irisin LEVELS IN PLASMA AND CEREBROSPINAL FLUID OF HUMANS
    42. Alteration of maternal serum Irisin levels in gestational diabetes mellitus
    43. Alteration of serum and cardiac tissue adropin, copeptin, Irisin and TRPM2 expressions in DOX treated male rats
    44. Alteration of the Irisin–brain-derived neurotrophic factor axis contributes to disturbance of mood in COPD patients
    45. Alterations of Irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running
    46. Alterations of Irisin, adropin, preptin and BDNF concentrations in coronary heart disease patients comorbid with depression
    47. Altered Irisin/BDNF axis parallels excessive daytime sleepiness in obstructive sleep apnea patients
    48. An Examination of the Changes in IL-15, CRP and Serum Irisin in Different Rest Intervals after a Session of Resistance Activity in the Elderly
    49. An Investigation into Irisin Levels: Acute and Chronic Effects of Combined Training and Its Association with Anthropometric Variables in Overweight Men
    50. An investigation of serum Irisin levels and inflammatory markers in fibromyalgia syndrome
    51. An Investigation of Serum Irisin Levels in Children Experiencing Convulsive Seizures
    52. AN OVERVİEW OF DİAGNOSTİC VALUES OF IRİSİN AND CYSTATİN C
    53. An update on the role of Irisin in the regulation of endocrine and metabolic functions
    54. An update on the validity of Irisin assays and the link between Irisin and hepatic metabolism
    55. An Updated Mini Review of Acute and Chronic Responses to Exercise Training-induced Irisin in Browning of White Fat
    56. Androgen receptors blockage does not influence the expression of Irisin in myocardium of endurance trained rats
    57. Anti-diabetic activity of recombinant Irisin in STZ-induced insulin-deficient diabetic mice
    58. Anti-inflammatory properties of Irisin, mediator of physical activity, are connected with TLR4/MyD88 signaling pathway activation
    59. Antidepressant-like and pro-neurogenic effects of physical exercise: The putative role of FNDC5/Irisin pathway
    60. Application of the transtheoretical model to predict self-care outcomes and serum Irisin level in the patients with type 2 diabetes
    61. Aquarobic exercises improve the serum blood Irisin and brain-derived neurotrophic factor levels in elderly women
    62. Aqueous humor heat-shock protein 70, periostin, and Irisin levels in patients with pseudoexfoliation syndrome
    63. Are Heart Muscle Irisin Levels and FNDC5 Gene Expression Regulated by Endurance and Resistance Exercises?
    64. Are skeletal muscle FNDC5 gene expression and Irisin release regulated by exercise and related to health?
    65. Assessing cardiac Irisin activities and their associations on coronary and endothelial activities to compare their recoveries from oxidative stress-induced cardiac cell …
    66. Assessment of Irisin concentration in women with stress urinary incontinence after using exracorporeal magnetic innervation (EXMI)-pilot study
    67. Assessment of Irisin levels in patients with bipolar depression and unipolar depression
    68. Assessment of Irisin, adiponectin and leptin levels in patients with schizophrenia
    69. ASSESSMENT OF SERUM Irisin IN OVERWEIGHT AND OBESE PATIENT WITH POLYCYSTIC OVARY SYNDROME
    70. Assessment of serum Irisin level in thyroid disorder
    71. Assessment of Serum Vitamin D and Irisin Levels in Obese Patients.
    72. Associaiton of Irisin and vaspin with clinical presentations of metabolic syndrome in patients with type 2 diabetes mellitus
    73. Association between circulating Irisin and C-reactive protein levels: A systematic review and meta-analysis
    74. Association between circulating Irisin and homocysteine in patients with nonalcoholic fatty liver disease
    75. Association between circulating Irisin and insulin resistance in non-diabetic adults: a meta-analysis
    76. Association between circulating Irisin levels and epicardial fat in patients with treatment-naïve overt hyperthyroidism
    77. Association between circulating Irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in …
    78. Association between insulin resistance and serum and salivary Irisin levels in patients with psoriasis vulgaris
    79. Association between Irisin and homocysteine in euglycemic and diabetic subjects
    80. Association between Irisin and major chronic diseases: a review
    81. Association between Irisin, hs-CRP, and metabolic status in children and adolescents with type 2 diabetes mellitus
    82. Association between plasma Irisin and glucose metabolism in pregnant women is modified by dietary n‐3 polyunsaturated fatty acid intake
    83. Association Between Plasma Irisin in Mid-Pregnancy and Postpartum Glucose Levels Among Chinese Women
    84. Association between plasma Irisin in pregnancy and postpartum glucose levels among Chinese women: a cohort study
    85. Association between Serum Irisin and TNFα in newly onset Diabetic type 2 in Iraqi patients
    86. Association between serum Irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study
    87. Association between serum Irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study
    88. Association between serum Irisin levels and non-alcoholic fatty liver disease in health screen examinees
    89. Association of circulating adiponectin, resistin, Irisin, nesfatin-1, apelin-12 and obestatin levels with hypertension and obesity
    90. Association of circulating Irisin and cardiopulmonary exercise capacity in healthy volunteers: results of the Study of Health in Pomerania
    91. Association of circulating Irisin concentrations with weight loss after Roux-en-Y gastric bypass surgery
    92. Association of Circulating Irisin Levels with Adiposity and Glucose Metabolic Profiles in a Middle-Aged Chinese Population: A Cross-Sectional Study
    93. Association of circulating Irisin levels with metabolic and metabolite profiles of Korean adolescents
    94. Association of circulating Irisin levels with normal weight obesity, glycemic and lipid profile
    95. Association of circulating Irisin with insulin resistance and oxidative stress in obese women
    96. ASSOCIATION OF CIRCULATING LEVELS OF Irisin AND FGF21 WITH ANTHROPOMETRIC AND METABOLIC PARAMETERS IN ELDERLY PATIENTS WITH …
    97. Association of Irisin and CRP levels with the radiographic severity of knee osteoarthritis
    98. Association of Irisin and FNDC5 rs16835198 G> T gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy. An Egyptian pilot study
    99. Association of Irisin and oxidative stress with biochemical parameters in patients with metabolic syndrome
    100. Association of Irisin circulating level with diabetic retinopathy: a case-control study
    101. Association of Irisin concentration with clinical Parameters in Obesity patient compared with sport individual in Iraqi population
    102. Association of Irisin concentrations with the presence of diabetic nephropathy and retinopathy
    103. Association of Irisin Hormone With Some Physiological And Inflammatory Parameters in Patients With Type 2 Diabetic Mellitus (T2DM) in Thi-Qar Province …
    104. Association of Irisin hormone with some physiological and inflammatory parameters of type 1 diabetic mellitus (TIDM) patiens in Thi-Qar province, Iraq
    105. Association of Irisin plasma levels with anthropometric parameters in children with underweight, normal weight, overweight, and obesity
    106. Association of Irisin serum concentration and muscle strength in normal-weight and overweight young women
    107. Association of Irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index
    108. Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index
    109. Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index
    110. Association of metabolic parameters and rs726344 in FNDC5 with serum Irisin concentrations
    111. Association of plasma fatty acid composition with plasma Irisin levels in normal weight and overweight/obese children
    112. Association of plasma Irisin level with prevalence of type 2 diabetes mellitus and physical activity
    113. Association of plasma Irisin with bone mineral density in a large chinese population using an extreme sampling design
    114. Association of polymorphisms of preptin, Irisin and adropin genes with susceptibility to coronary artery disease and hypertension
    115. Association of serum concentrations of Irisin and the adipokines adiponectin and leptin with epicardial fat in cardiovascular surgery patients
    116. Association of Serum Fibroblast Growth Factor 21 and Irisin with Insulin Sensitivity Markers and Serum Lipids in 12-year-old Children
    117. Association of serum Irisin and body composition with chronic kidney disease in obese Chinese adults: a cross-sectional study
    118. ASSOCIATION OF SERUM Irisin CONCENTRATION WITH CORONARY ARTERY DISEASE IN PATIENTS WITH TYPE 2 DIABETES
    119. Association of Serum Irisin Concentration with Coronary Artery Disease in Patients with Type 2 Diabetes
    120. Association of serum Irisin concentrations with presence and severity of coronary artery disease
    121. Association of serum Irisin concentrations with the presence and severity of obstructive sleep apnea syndrome
    122. Association of serum Irisin with 25 (OH) VD3 and other metabolic indicators in patients with polycystic ovarian syndrome
    123. Association of serum Irisin with metabolic syndrome in obese Chinese adults
    124. Association of the serum Irisin level with obstructive sleep apnea: a body mass index-and physical activity-matched study
    125. Associations of apelin, leptin, Irisin, ghrelin, insulin, glucose levels, and lipid parameters with physical activity during eight weeks of regular exercise training
    126. Associations of betatrophin levels with Irisin in Chinese women with normal glucose tolerance
    127. Associations of circulating Irisin concentrations with cardiometabolic risk factors among children vary by physical activity or sedentary time levels
    128. Associations of Preoperative Irisin Levels of Paired Cerebrospinal Fluid and Plasma with Physical Dysfunction and Muscle Wasting Severity in Residents of Surgery …
    129. Associations of Serum Irisin Level With Brachial Ankle Pulse Wave Velocity and Ankle Brachial Index in Hospitalized Patients
    130. Auricular acupuncture induces FNDC5/Irisin and attenuates obese inflammation in mice
    131. Autonomic function may not modulate Irisin release in healthy adults: findings from a randomized cross-over study
    132. Basic research: Irisin–behind the benefits of exercise
    133. Beneficial effect of voluntary exercise on experimental colitis in mice fed a high-fat diet: the role of Irisin, adiponectin and proinflammatory biomarkers
    134. Biochemical and biological effects of Irisin in a model of diabetes mellitus
    135. Blind spot for sedentarism: redefining the diseasome of physical inactivity in view of circadian system and the Irisin/BDNF axis
    136. Blunted circulating Irisin in adults with type 1 diabetes during aerobic exercise in a hot environment: a pilot study
    137. Bone mineral density in relation to polycystic ovary syndrome: an insight into Irisin and insulin
    138. Bone mineral density in relation to polycystic ovary syndrome: an insight into Irisin and insulin
    139. Boning up on Irisin
    140. Both experimental hypothyroidism and hyperthyroidism increase cardiac Irisin levels in rats.
    141. Both hypothyroidism and hyperthyroidism increase plasma Irisin levels in rats
    142. Brown adipose tissue and browning agents: Irisin and FGF21 in the development of obesity in children and adolescents
    143. Brown adipose tissue in women with polycystic ovary syndrome: relationship with body measures, plasma Irisin levels and the use of metformin
    144. Browning of white fat: does Irisin play a role in humans
    145. C73 NEW MECHANISMS AND THERAPIES IN COPD: Decreased Level Of Irisin, A Skeletal Muscle Cell-Derived Myokine, Is Involved In Emphysema Associated With …
    146. Can Irisin be a linker between physical activity and brain function?
    147. Can Pre-analytical Mistake Bearing Irisin Concentrations Be an Indicator of Coronary Artery Disease?
    148. Can resistance exercise alter Irisin levels and expression profiles of FNDC5 and UCP1 in rats?
    149. Can the Irisin be a biomarker for prostate cancer? A case control study
    150. Cardiometabolic health, visceral fat and circulating Irisin levels: results from a real-world weight loss study
    151. Central and peripheral Irisin differentially regulate blood pressure
    152. Central inhibitory effects on feeding induced by the adipo-myokine Irisin
    153. Central Irisin administration affords antidepressant-like effect and modulates neuroplasticity-related genes in the hippocampus and prefrontal cortex of mice
    154. Central Irisin administration suppresses thyroid hormone production but increases energy consumption in rats
    155. Cerebrospinal fluid Irisin correlates with amyloid-𝜷, BDNF, and cognition in Alzheimer’s disease
    156. Cerebrospinal fluid Irisin correlates with amyloid‐β, BDNF, and cognition in Alzheimer’s disease
    157. Changes and influencing factors of serum Irisin and Galanin level in patients with type 2 diabetes mellitus and obesity
    158. Changes in Inflammatory Cytokines and Irisin in Response to High Intensity Swimming in Adolescent versus Adult Male Swimmers
    159. Changes in Irisin levels in patients with hyperemesis gravidarum
    160. CHANGES IN Irisin RELEASE IN RESPONSE TO PERIPHERAL KISSPEPTIN-10 ADMINISTRATION IN HEALTHY AND OBESE ADULT MEN
    161. Changes in Irisin, titin and dystrophin concentrations in patients with overt thyroid dysfunction
    162. Changes in thyroid hormone levels within the normal and/or subclinical hyper-or hypothyroid range do not affect circulating Irisin levels in humans
    163. Changes of Irisin in patients with end-stage renal disease before and after hemodialysis
    164. Changes of Irisin in patients with end-stage renal disease before and after hemodialysis
    165. Characterization of serum Irisin in patients with severe acute pancreatitis
    166. Characterization of the metabolic effects of Irisin on skeletal muscle in vitro
    167. CHARACTERIZATION OF THE ROLE OF Irisin IN SKELETAL MUSCLE GROWTH AND REPAIR
    168. Chemical Synthesis of the 12 kDa Human Myokine Irisin by α‐Ketoacid‐Hydroxylamine (KAHA) Ligation
    169. Chest Pain is Associated With Decreased Irisin Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease
    170. Chicoric acid does not restore palmitate-induced decrease in Irisin levels in PBMCs of newly diagnosed patients with T2D and healthy subjects
    171. Chronic exercise training and circulating Irisin in adults: a meta-analysis
    172. Chronic Irisin exposure decreases sexual incentive motivation in female rats
    173. Circulating Adipocyte fatty acid binding protein (FABP4) levels are associated with Irisin in the middle-aged general Chinese population
    174. Circulating Irisin and adiponectin levels are positively associated with atrial fibrillation
    175. Circulating Irisin and chemerin levels as predictors of seizure control in children with idiopathic epilepsy
    176. Circulating Irisin and esRAGE as early biomarkers of decline of metabolic health
    177. Circulating Irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid
    178. Circulating Irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome
    179. Circulating Irisin and myostatin as markers of muscle strength and physical condition in elderly subjects
    180. Circulating Irisin concentrations are associated with a favourable lipid profile in the general population
    181. Circulating Irisin concentrations in rat models of thyroid dysfunction—effect of exercise
    182. Circulating Irisin confirmed by mass spectrometry
    183. Circulating Irisin detection: Does it really work?
    184. Circulating Irisin in Healthy Adults: Changes after Acute Exercise, Correlation with Body Composition, and Energy Expenditure Parameters in Cross-Sectional Study
    185. Circulating Irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body …
    186. Circulating Irisin in patients with polycystic ovary syndrome: a meta-analysis
    187. Circulating Irisin in relation to insulin resistance and the metabolic syndrome
    188. Circulating Irisin is a Novel Biomarker Providing Prognostic Information in Patients With Heart Failure With Reduced Ejection Fraction
    189. Circulating Irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab …
    190. Circulating Irisin is increased in type 2 diabetes mellitus and correlates with fasting glucose levels
    191. Circulating Irisin is linked to bone mineral density in geriatric Chinese men
    192. Circulating Irisin is lower in gestational diabetes mellitus
    193. Circulating Irisin is reduced in male patients with type 1 and type 2 myotonic dystrophies
    194. Circulating Irisin Level and Thyroid Dysfunction: A Systematic Review and Meta-Analysis
    195. Circulating Irisin Level as an Early Biomarker of Decline of Metabolic Health
    196. Circulating Irisin Level as an Early Biomarker of Decline of Metabolic Health
    197. Circulating Irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events
    198. Circulating Irisin levels and muscle FNDC5 mRNA expression are independent of IL-15 levels in mice
    199. Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study
    200. Circulating Irisin levels are associated with lipid and uric acid metabolism in a Chinese population
    201. Circulating Irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin …
    202. Circulating Irisin Levels Are Not Affected by Coffee Intake: A Randomized Controlled
    203. Circulating Irisin levels are not affected by coffee intake: a randomized controlled trial
    204. Circulating Irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients
    205. Circulating Irisin levels are not regulated by nutritional status, obesity, or leptin levels in rodents
    206. Circulating Irisin Levels Are Not Regulated by Nutritional Status, Obesity, or Leptin Levels in Rodents
    207. Circulating Irisin levels are not regulated by nutritional status, obesity, or leptin levels in rodents
    208. Circulating Irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy
    209. Circulating Irisin levels are positively associated with metabolic risk factors in sedentary subjects
    210. Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease
    211. Circulating Irisin levels as a predictive biomarker for sarcopenia: A cross‐sectional community‐based study
    212. Circulating Irisin levels in children with GH deficiency before and after 1 year of GH treatment
    213. Circulating Irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study
    214. Circulating Irisin levels in newly diagnosed obstructive sleep apnea patients
    215. Circulating Irisin Levels in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    216. Circulating Irisin levels in response to acute and chronic exercise in obese adults
    217. Circulating Irisin levels of prenatal and postnatal patients with gestational diabetes mellitus: A systematic review and meta-analysis
    218. Circulating Irisin levels reflect visceral adiposity in non-diabetic patients undergoing hemodialysis
    219. Circulating Irisin underscores the development of polycystic ovary syndrome
    220. Circulating Irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk
    221. Circulating levels of betatrophin and Irisin are not associated with pancreatic β-cell function in previously diagnosed type 2 diabetes mellitus patients
    222. Circulating levels of Irisin in hypopituitary and normal subjects
    223. Circulating levels of Irisin in middle-aged first-degree relatives of type 2 diabetes mellitus—correlation with pancreatic β-cell function
    224. Circulating levels of Irisin in obese individuals at genetic risk for Alzheimer’s disease: Correlations with amyloid-β, metabolic, and neurocognitive indices
    225. Circulating levels of Irisin in patients with anorexia nervosa and different stages of obesity–correlation with body mass index
    226. Circulating levels of Irisin is elevated in hypothyroidism, a case-control study
    227. Circulating levels of Irisin is elevated in patients suffering from hypothyroidism and obesity in Hashimoto
    228. Circulating sclerostin and Irisin are related and interact with gender to influence adiposity in adults with prediabetes
    229. Circulating serum Irisin levels in obesity and type 2 diabetes mellitus
    230. Circulating Serum Irisin Levels in Obesity and Type 2 Diabetes Mellitus
    231. Clinical impact of circulating Irisin on classified coronary plaque characteristics
    232. Cloning, prokaryotic expression of human (Homo sapiens) Irisin gene and purification of recombinant protein.
    233. Codon optimization and expression of Irisin in Pichia pastoris GS115
    234. Colostrum and mature breast milk analysis of serum Irisin and sterol regulatory element-binding proteins-1c in gestational diabetes mellitus
    235. Combination of melatonin and Irisin ameliorates lipopolysaccharide‐induced cardiac dysfunction through suppressing the Mst1–JNK pathways
    236. Combined Training Increases the Level of Irisin, Functional Fitness, and Muscle Function in Older Women with Osteosarcopenic Obesity
    237. Combined training, FNDC5/Irisin levels and metabolic markers in obese men: A randomised controlled trial
    238. Comment on Wu and Spiegelman. Irisin ERKs the Fat. Diabetes 2014; 63: 381− 383
    239. Comment on: Effect of sleeve gastrectomy on the expression of Meteorin-like (METRNL) and Irisin (FNDC5) in muscle and brown adipose tissue and its impact on …
    240. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived ‘browning’factor Irisin, determines insulin sensitivity
    241. Common single nucleotide polymorphisms in the FNDC5 gene are associated with glucose metabolism but do not affect serum Irisin levels in Japanese men with low …
    242. Comparison of Irisin hormone expression between thyroid cancer tissues and oncocytic variant cells
    243. Comparison of Irisin Serum Healthy Untrained Males on Treadmill Exercises by Increasing Gradually Speed Vs Inclination
    244. Comparison of the effect of period of resistance, aerobic and concurrent training on Irisin, CRP serum levels in obese women
    245. Comparison of the effects of regular aerobic training Irisin serum changes in sedentary obese men
    246. Comparison of the effects of two different intensities of combined training on Irisin, betatrophin, and insulin levels in women with type 2 diabetes
    247. Comparison of the Effects of Two Different Intensities of Combined Training on Irisin, Betatrophin, and Insulin Levels inWomen with Type 2 Diabetes
    248. Comparison the effect of eight weeks aerobic training with moderate and high intensities on serum levels of Irisin and Uncoupling Protein 1 (UCP-1) in white adipose …
    249. Comparsion of the effect of resistance program training with different intensities on serum Irisin levels in sedentary young women
    250. Compensatory increased Irisin levels in gestational diabetes mellitus
    251. Comprehensive evaluation of Irisin levels in fetomaternal circulation of pregnant women with obesity or gestational diabetes mellitus
    252. Concentrations of Circulating Irisin and Myostatin in Race and Endurace Purebred Arabian Horses—Preliminary Study
    253. Construction of a Pichia pastoris strain efficiently secreting Irisin and assessment of its bioactivity in HepG2 cells
    254. Copeptin, adropin and Irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus
    255. Cord blood Irisin at the extremes of fetal growth
    256. Cord blood Irisin levels are positively correlated with birth weight in newborn infants
    257. Correlates and Consequences of High Serum Irisin Concentration in Patients on Hemodialysis: A Longitudinal Analysis
    258. Correlation among serum levels of Irisin, insulin resistance and abdominal obesityin patients with first-episode schizophrenia
    259. Correlation between the blood level of Irisin and the severity of acute myocardial infarction in exercise-trained rats
    260. Correlation of Moderate-Intensity Physical Exercise on Irisin, Oxidized-LDL and HDL Level in≥ 50 Years Old Obese Men
    261. Correlations between serum testosterone and Irisin levels in a sample of Egyptian men with metabolic syndrome;(case-control study)
    262. Corrigendum to “Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing …
    263. Corrigendum to: Ursolic Acid-Induced Elevation of Serum Irisin Augments Muscle Strength During Resistance Training in Men
    264. Corrigendum to” Irisin Attenuates Angiotensin II-induced Cardiac Fibrosis via Nrf2 Mediated Inhibition of ROS/TGFβ1/Smad2/3 Signaling Axis”[Chem Biol Interact 302 …
    265. Could Irisin levels be affected by physical activity in patients with schizophrenia?
    266. Could serum levels of Irisin be used in gestational diabetes predicting?
    267. COVID-19: Could Irisin Become the Handyman Myokine of the 21st Century
    268. CROSS-TALK BETWEEN MUSCLE AND CARTILAGE: THE MYOKINE Irisin ATTENUATES OSTEOARTHRITIS-RELATED CARTILAGE DEGENERATION
    269. Crossfit training changes brain-derived neurotrophic factor and Irisin levels at rest, after wingate and progressive tests, and improves aerobic capacity and body …
    270. Crosstalk between muscle and bone via the muscle-myokine Irisin
    271. Cystathionine γ-lyase-hydrogen sulfide (H2S) deficiency downregulates muscle myokine Fndc5/Irisin and glucose metabolism in C2C12 myotubes and gastrocnemius …
    272. D41 COPD: BIOMARKERS IN STABLE DISEASE AND EXACERBATIONS: Evaluation Of The Value Of Irisin Levels In Chronic Obstructive Pulmonary Disease (COPD) …
    273. Decrease in Irisin in patients with chronic kidney disease
    274. Decreased concentration of Irisin is associated with poor functional outcome in ischemic stroke
    275. Decreased Irisin secretion contributes to muscle insulin resistance in high-fat diet mice
    276. Decreased level of Irisin, a skeletal muscle cell-derived myokine, is associated with post-stroke depression in the ischemic stroke population
    277. Decreased Level Of Irisin, A Skeletal Muscle Cell-Derived Myokine, Is Involved In Emphysema Associated With Chronic Obstructive Pulmonary Disease Through …
    278. Decreased levels of Irisin, a skeletal muscle cell-derived myokine, are related to emphysema associated with chronic obstructive pulmonary disease
    279. Decreased saliva/serum Irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology
    280. Decreased Serum Levels of Irisin are Associated with the Development of Chronic Lung Allograft Dysfunction after Bilateral Living-Donor Lobar Lung Transplantation
    281. Delivery vehicle of muscle-derived Irisin based on silk/calcium silicate/sodium alginate composite scaffold for bone regeneration
    282. Detection and quantitation of circulating human Irisin by tandem mass spectrometry
    283. Detection and quantitation of Irisin in human cerebrospinal fluid by tandem mass spectrometry
    284. Diabetes Mellitus Influences the Pattern of Distribution of Irisin in Pancreatic Islet Cells
    285. Diet quality is associated with circulating C-reactive protein but not Irisin levels in humans
    286. Differences in analytical and biological results between older and newer lots of a widely used Irisin immunoassay question the validity of previous studies
    287. Differentiating SGBS adipocytes respond to PPARγ stimulation, Irisin and BMP7 by functional browning and beige characteristics
    288. Differentiating SGBS adipocytes respond to PPARγ stimulation, Irisin and BMP7 by functional browning and beige characteristics
    289. Dihydromyricetin stimulates Irisin secretion partially via the PGC-1α pathway
    290. Disordered metabolism in mice lacking Irisin
    291. Does high intensity exercise affects Irisin plasma levels in hemodialysis patients? A pilot study
    292. Does Irisin has neuroprotective effect against diabetes induced neuropathy in male rats?
    293. Does Irisin have a BRITE future as a therapeutic agent in humans?
    294. Does Irisin Have an Effect on Female Reproductive Function? Initial in-Vitro Studies
    295. Does Irisin Link Physical Exercise with Alzheimer’s Disease?
    296. Does one bout of high intensity resistance training change circulatory levels of Irisin?
    297. Dojuksan ameliorates tubulointerstitial fibrosis through Irisin-mediated muscle-kidney crosstalk
    298. Down-regulation of soluble α-Klotho is associated with reduction in serum Irisin levels in chronic obstructive pulmonary disease
    299. DSS-induced colitis produces inflammation-induced bone loss while Irisin treatment mitigates the inflammatory state in both gut and bone
    300. Early life adversity is associated with elevated levels of circulating leptin, Irisin, and decreased levels of adiponectin in midlife adults
    301. Eccentric resistance training and β-hydroxy-β-methylbutyrate free acid affects muscle PGC-1α expression and serum Irisin, nesfatin-1 and resistin in rats
    302. Editorial Retraction: A Review on the Role of Irisin in Insulin Resistance and Type 2 Diabetes Mellitus
    303. Effect of 12 weeks of light and heavy interval training on the level of Irisin and fibroblast growth factor 21 in obese and overweight women: A clinical trial study
    304. Effect of 14 days of experimental horizontal bed rest on circulating levels of Irisin
    305. Effect of 8 Weeks Exercise On Irisin in Obese Women
    306. Effect of 8 weeks of hypocaloric diet and physical activity on thyroid hormones, Irisin and insulin sensitivity in obese otherwise healthy subjects.
    307. Effect of 8 Weeks Resistance Training and Irisin Injection on BDNF and Spatial Memory of Male Mice
    308. Effect of Acute Handball Training on Irisin, Leptin and Some Biochemical Parameters for Adolescence Handball Players.
    309. Effect of Acute Resistance Training on Plasma Irisin Protein Level and Expression of Muscle FNDC5 and Adipose Tissue UCP1 Genes in Male Rats.
    310. Effect of Adipose Tissue-Derived Stem Cell Transplantation and Six Weeks of Aerobic Exercise on FNDC5 and Irisin Levels in Streptozotocin-Induced …
    311. Effect of aerobic training and resistance training on circulating Irisin level and their association with change of body composition in overweight/obese adults: a …
    312. Effect of aerobic training intensity on Irisin in streptozotocin-induced diabetic rats
    313. Effect of an acute exercise bout on immediate post‐exercise Irisin concentration in adults: a meta‐analysis
    314. Effect of carnosine supplementation on apoptosis and Irisin, total oxidant and antioxidants levels in the serum, liver and lung tissues in rats exposed to formaldehyde …
    315. Effect of carnosine, methylprednisolone and their combined application on Irisin levels in the plasma and brain of rats with acute spinal cord injury
    316. Effect of chronic aerobic exercise training on serum Irisin level in type 2 diabetic rats
    317. Effect of Chronic Exercise on Irisin Plasma Level and Browning of White Adipose Tissue in Rat Models with Obesity or Type 2 Diabetes Mellitus
    318. Effect of cold and moderate water immersion during resistance exercise on plasma Irisin protein response in rats
    319. Effect of Different Exercise Mode and Ur-solic Acid Supplementation on FNDC5 and UCP1 Gene Expression and Plasma Irisin in Rats
    320. Effect of different rest interval between sets of resistance exercise on serum Irisin and blood lactate levels in obese male children
    321. Effect of Eight Weeks’ Resistance Training on Serum Levels of Irisin and Lipid Profile in Overweight Men’s with Nonalcoholic Fatty Liver Disease
    322. Effect of electroacupuncture combined with treadmill exercise on body weight and expression of PGC-1α, Irisin and AMPK in skeletal muscle of diet-induced obesity …
    323. Effect of Ethanol Diet on the circulating levels of Myonectin and Irisin
    324. Effect of exercise intensity on cerebral and muscular brain-derived neurotrophic factor. Connection with the myokine Irisin
    325. Effect of exercise on concentrations of Irisin in overweight individuals: a systematic review
    326. Effect of exercise on serum Irisin level in normal and diabetic rats
    327. Effect of exercise-induced Irisin on myocardial fibrosis
    328. Effect of High Intensity Interval Training (HIIT) on Level of Irisin and Insulin Resistance Index in Rats
    329. Effect of High-Intensity Interval Training (HIIT) on the Levels of Irisin and Interleukin-10 in Overweight Men
    330. Effect of HIIT with Tabata Protocol on Serum Irisin, Physical Performance, and Body Composition in Men
    331. Effect of Irisin on Endometrial Function in Obese Rats
    332. Effect of Irisin on endometrial receptivity of rats with polycystic ovary syndrome
    333. Effect of Irisin on Experimentally-Induced Preeclampsia in Female Albino Rats
    334. Effect of Irisin on hypoxic-ischemic brain damage in neonatal rats
    335. Effect of Irisin on LIF and integrin αvβ3 in rats of implantation failure
    336. Effect of Irisin on Pressure Overload–Induced Cardiac Remodeling
    337. Effect of Long-Term Moderate Physical Exercise on Irisin between Normal Weight and Obese Men
    338. Effect of metformin treatment on insulin resistance markers, and circulating Irisin in women with polycystic ovarian syndrome (PCOS)
    339. Effect of Mixed‐Carotenoid Supplementation and Physical Activity on Irisin and Adiponectin: A 6‐Month Double Blind Placebo‐Controlled Pilot Study in Children with …
    340. Effect of obesity and exercise on the expression of the novel myokines, Myonectin and Irisin
    341. Effect of one session of high-intensity resistive activity on Irisin, IL-15, IL-6 and TNF-α plasma levels in sedentary young women
    342. Effect of single bout downhill running on the serum Irisin concentrations in rats
    343. Effect of sitagliptin on expression of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1 α and Irisin in a rat model of type 2 diabetes mellitus
    344. Effect of six weeks high intensity interval training with turmeric supplementation on Irisin and UCP1 in obese females
    345. Effect of sleeve gastrectomy on the expression of meteorin-like (METRNL) and Irisin (FNDC5) in muscle and brown adipose tissue and its impact on uncoupling …
    346. Effect of sprint training on resting serum Irisin concentration—sprint training once daily vs. twice every other day
    347. Effect of Swimming on Serum Irisin Levels in Experimentally-Induced Rat Model of Postmenopausal Osteoporosis
    348. Effect of Swimming Training along with Omega-3 Intake on Irisin and Body Composition in Obese Girls with Down Syndrome
    349. Effect of training and gender on plasma Irisin, leptin, and insulin levels
    350. Effect of two weeks of sprint interval training combined with omega-3 consumption on serum levels of Irisin, BDNF and Lipid profile in overweight girls
    351. Effect of Two-Week Swimming Training on the Expression of Irisin Protein in Lumbar Spine of Rats with Neuropathic Pain
    352. Effect of ursodeoxycholic acid therapy due to pregnant intrahepatic cholestasis on chemerin and Irisin levels
    353. Effect of vitamin D supplementation and muscular exercise on Irisin serum level and related metabolic parameters in type II diabetic albino rats
    354. Effect of Vitamin D3 Administration on Irisin Levels in Vitamin D Deficient Rat Model
    355. Effect of Yoga Exercises on Irisin Hormone in Obese People
    356. Effects and molecular mechanism of GST-Irisin on lipolysis and autocrine function in 3T3-L1 adipocytes
    357. Effects and underlying mechanisms of Irisin on the proliferation and apoptosis of pancreatic β cells
    358. Effects of 12 weeks Combined exercise on Physical fitness, Irisin and BNDF in White-collar woman workers
    359. Effects of 12 weeks resistance training on serum Irisin in older male adults
    360. Effects of 8-week combined training (aerobic and resistance) on serum levels of Irisin and leptin in overweight men
    361. Effects of a 1‐year exercise and lifestyle intervention on Irisin, adipokines, and inflammatory markers in obese children
    362. Effects of a Combined Endurance/Strength Training Program on Circulating Irisin Levels in Overweight/Obese Men and Women with Type 2 Diabetes Mellitus
    363. Effects of Aerobic and Resistance Training on Expression of Circulating Irisin
    364. Effects of aerobic exercise in manipulated environment on serum levels of BDNF, Irisin and Cathepsin B in healthy active men
    365. Effects of aerobic training, resistance training, or both on circulating Irisin and myostatin in untrained women
    366. Effects of aged garlic extract and endurance exercise on skeletal muscle FNDC-5 and circulating Irisin in high-fat-diet rat models
    367. Effects of body weight reduction on serum Irisin and metabolic parameters in obese subjects
    368. Effects of Carnosine and Vitamin E on Nucleobindin 2 (NUCB2)/nesfatin-1, Ghrelin, Adropin, and Irisin in Experimentally Induced Ovarian Torsion
    369. Effects of carnosine, ankaferd and silver sulfadiazine on an experimental burn model; roles of Irisin and HSP70
    370. Effects of central fibroblast growth factor 21 and Irisin in anxiety-like behavior.
    371. Effects of central Irisin administration on the uncoupling proteins in rat brain
    372. Effects of chronic Irisin administration on body weight and reproductive organ weights in rats.
    373. Effects of Combined Exercise on Irisin, Body Composition and Glucose Metabolism in Obese Elderly Women with Type 2 Diabetes Mellitus
    374. Effects of concurrent training on Irisin and fibronectin type-III domain containing 5 (FNDC5) expression in visceral adipose tissue in type-2 diabetic rats
    375. Effects of delivery on maternal & neonatal Irisin levels in normal and preeclamptic pregnant women
    376. Effects of dietary macronutrient composition on FNDC5 and Irisin in mice skeletal muscle
    377. Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis
    378. Effects of Exercise on Serum Levels of Irisin in High School Girls
    379. Effects of exercise on the circulating concentrations of Irisin in healthy adult individuals: A review
    380. Effects of green tea extract supplementation and endurance training on Irisin, pro-inflammatory cytokines, and adiponectin concentrations in overweight middle-aged …
    381. Effects of high-intensity circuit training on muscle strength, Irisin, FGF-21, and adiponectin in obese female college students
    382. Effects of high-intensity resistance training on circulating levels of Irisin in healthy adults: A randomized controlled trial
    383. Effects of high-intensity treadmill training on timeliness and plasticity expression of Irisin in mice
    384. Effects of hippocampal microinjection of Irisin, an exercise-induced myokine, on spatial and passive avoidance learning and memory in male rats
    385. Effects of Hypnotherapy on Weight Loss and thus on Serum Leptin, Adiponectin, and Irisin Levels in Obese Patients
    386. Effects of Interval Training on Irisin and Insulin Resistance in Overweight Men
    387. Effects of intra-dentate gyrus microinjection of myokine Irisin on long-term potentiation in male rats
    388. Effects of intracerebroventricular administration of Irisin on the hypothalamus–pituitary–gonadal axis in male rats
    389. Effects of Irisin and exercise on metabolic parameters and reproductive hormone levels in high-fat diet-induced obese female mice
    390. Effects of Irisin compared with exercise on specific metabolic and obesity parameters in female mice with obesity
    391. Effects of Irisin on osteoblast apoptosis and osteoporosis in postmenopausal osteoporosis rats through upregulating Nrf2 and inhibiting NLRP3 …
    392. Effects of Irisin on proliferation, apoptosis, migration and invasion of human cholangiocarcinoma cell line Hucct-1
    393. Effects of Irisin on the differentiation and browning of human visceral white adipocytes
    394. Effects of Irisin on the dysfunction of blood–brain barrier in rats after focal cerebral ischemia/reperfusion
    395. Effects of Irisin on the Reproductive Parameters in High-Fat Diet-Induced Obese Male Rats
    396. Effects of lifestyle modification and metformin on Irisin and FGF 21 among HIV‐infected subjects with the metabolic syndrome
    397. Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo
    398. Effects of melatonin on lipid metabolism and circulating Irisin in diet‐induced obese Sprague‐Dawley rats
    399. Effects of melatonin on lipid metabolism and circulating Irisin in sprague-dawley rats with diet-induced obesity
    400. Effects of obesity, diabetes and exercise on Fndc5 gene expression and Irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies
    401. Effects of partial vascular occlusion on Irisin responses to loaded muscle contractions
    402. Effects of recombinant Irisin on body mass index, serum insulin, luteinizing hormone and testosterone levels in obese female BALB/c mice
    403. Effects of resveratrol, grape juice or red wine consumption Irisin levels and fibronectin type III domain containing protein 5 and uncoupoling protein gene …
    404. Effects of running a marathon on Irisin concentration in men aged over 50
    405. Effects of Short Term Metformin Treatment on Brown Adipose Tissue Activity and Plasma Irisin Levels in Women with Polycystic Ovary Syndrome: A …
    406. Effects of sprint interval exercise dose and sex on circulating Irisin and redox status markers in adolescent swimmers
    407. Effects of Strength Training on Serum Levels of Irisin and Myostatin Hormones, and Their Association with Lipid Profiles in Untrained Women
    408. Effects of swimming exercise on serum Irisin and bone FNDC5 in rat models of high-fat diet-induced osteoporosis
    409. Effects of the exercise‐inducible myokine Irisin on malignant and non‐malignant breast epithelial cell behavior in vitro